SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    María Luisa Gutiérrez García, Sonia Alonso Lopez, María Dolores Martín Rios, Patricia Sanmartin Fenollera, Sandra Agudo Fernandez, Conrado Manuel Fernández Rodriguez, Reactivación del virus de la hepatitis B en pacientes tratados con rituximab: incidencia y factores de riesgo, Gastroenterología y Hepatología, 2014,

    CrossRef

  2. 2
    Seok Jin Kim, Chiun Hsu, Yu-Qin Song, Kevin Tay, Xiao-Nan Hong, Junning Cao, Jin Seok Kim, Hyeon Seok Eom, Joon Hyeok Lee, Jun Zhu, Kian-Meng Chang, Arry Harryanto Reksodiputro, Daryl Tan, Yeow Tee Goh, Jejung Lee, Tanin Intragumtornchai, Wee-Joo Chng, Ann-Lii Cheng, Soon Thye Lim, Cheolwon Suh, Yok-Lam Kwong, Won Seog Kim, Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group, European Journal of Cancer, 2013, 49, 16, 3486

    CrossRef

  3. 3
    Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao, Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management, Hepatology International, 2013, 7, 2, 316

    CrossRef

  4. 4
    Hua-Jie Dong, Ling-Na Ni, Gui-Feng Sheng, Hong-Lei Song, Jian-Zhong Xu, Yang Ling, Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis, Journal of Clinical Virology, 2013, 57, 3, 209

    CrossRef

  5. 5
    Makoto Oketani, Akio Ido, Hirofumi Uto, Hirohito Tsubouchi, Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy, Hepatology Research, 2012, 42, 7
  6. 6
    A. M. Evens, B. D. Jovanovic, Y.- C. Su, D. W. Raisch, D. Ganger, S. M. Belknap, M.- S. Dai, B.- C. C. Chiu, B. Fintel, Y. Cheng, S.- S. Chuang, M.- Y. Lee, T.- Y. Chen, S.- F. Lin, C.- Y. Kuo, Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports, Annals of Oncology, 2011, 22, 5, 1170

    CrossRef

  7. You have free access to this content7
    John S Lubel, Peter W Angus, Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management, Journal of Gastroenterology and Hepatology, 2010, 25, 5
  8. You have free access to this content8
    Yu Xuan Koo, Daniel S. W. Tan, Iain B. Tan, Miriam Tao, Wan Cheng Chow, Soon Thye Lim, Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy, Cancer, 2010, 116, 1
  9. 9
    Philippe Colson, Patrick Borentain, Diane Coso, Christian Chabannon, Catherine Tamalet, René Gérolami, Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma, British Journal of Haematology, 2008, 143, 1
  10. 10
    Holbrook E. Kohrt, Daniel L. Ouyang, Emmet B. Keeffe, Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection, Clinics in Liver Disease, 2007, 11, 4, 965

    CrossRef

  11. 11
    Sercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, Didem Sener Dede, Omer Dizdar, Kadri Altundag, Ibrahim Barista, Rituximab-related viral infections in lymphoma patients, Leukemia & Lymphoma, 2007, 48, 7, 1307

    CrossRef